A modeled high-response dose is an estimate, not a guaranteed success percentage in a new sample.
Study findings
The two-step study first estimated remimazolam and propofol doses for suppressing movement during elderly gastroscopy with sufentanil. Forty-six people completed dose estimation. In a subsequent 240-patient comparison using the estimated ED95 doses, effective-anesthesia rates were 78% and 83%, without a statistically clear difference.
What limits the conclusion
The estimation and validation stages had different samples. Response variability, the definition of effectiveness and the combined-drug context matter. Equivalent estimated response targets do not mean equivalent milligram doses or identical pharmacological exposure.
Implications for case review
Keep the second-stage observed rates alongside the ED95 label. Neither dose estimate is a toxic threshold or an assurance for an individual patient. For case reconstruction, ask which endpoint was predicted, which was subsequently observed and whether rescue medication changed the course.
Source and related reading
Source: PMC10984999, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Increasing Dental Midazolam Claims Did Not Demonstrate Improved Safety.
Leave a Reply